Novo Nordisk has entered into a new collaboration with UK public sector organisations to provide a new integrated model of specialist diabetes care.
King’s Health Partners Academic Health Sciences Centre, which comprises King’s College London and Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS foundation trusts launched the i3-diabetes scheme at the end of January in partnership with Novo Nordisk.
Drawing on the expertise on all of the partners involved, the project will focus on developing a new model of diabetes care that is more integrated with community and primary care. There will be a specific focus on the current shift to more community-based services to deliver better outcomes for patients.
The project will run for five years and the aim is to improve care coordination and develop a holistic risk stratification system to make sure that the care offered is suited to patients’ needs as a whole.
Peter Meeus, vice-president of Novo Nordisk in the UK and Ireland, said: “The i3-diabetes programme will offer an opportunity for all to learn how to drive improvements in outcomes without the usual concurrent increases in cost.”